Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy POSEIDON-DCM Trial

Overview of attention for article published in JACC, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 4 news outlets
twitter: 28 X users
patent: 1 patent

facebook: 3 Facebook pages
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 294 Mendeley

So far, Altmetric has seen 36 X posts from 28 X users, with an upper bound of 239,799 followers.

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy https://t.co/F2NRezxSP8

A clinical trial of elderly patients shows the superiority of donated adult stem cells to reverse heart disease vs autologous stems. https://t.co/4ryoovLyYz!

These findings demonstrated safety & clinically meaningful efficacy of allo-hMSC versus auto-hMSC in NIDCM patients. https://t.co/wGu3B6StG5

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 32 additional X posts.